311 related articles for article (PubMed ID: 12014918)
21. Dietary modification of human macular pigment density.
Hammond BR; Johnson EJ; Russell RM; Krinsky NI; Yeum KJ; Edwards RB; Snodderly DM
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1795-801. PubMed ID: 9286268
[TBL] [Abstract][Full Text] [Related]
22. Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance.
Kvansakul J; Rodriguez-Carmona M; Edgar DF; Barker FM; Köpcke W; Schalch W; Barbur JL
Ophthalmic Physiol Opt; 2006 Jul; 26(4):362-71. PubMed ID: 16792735
[TBL] [Abstract][Full Text] [Related]
23. Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin - the LUXEA (LUtein Xanthophyll Eye Accumulation) study.
Schalch W; Cohn W; Barker FM; Köpcke W; Mellerio J; Bird AC; Robson AG; Fitzke FF; van Kuijk FJ
Arch Biochem Biophys; 2007 Feb; 458(2):128-35. PubMed ID: 17084803
[TBL] [Abstract][Full Text] [Related]
24. Comparison of dietary supplementation with lutein diacetate and lutein: a pilot study of the effects on serum and macular pigment.
Landrum J; Bone R; Mendez V; Valenciaga A; Babino D
Acta Biochim Pol; 2012; 59(1):167-9. PubMed ID: 22428144
[TBL] [Abstract][Full Text] [Related]
25. The effects of supplementation with lutein and/or zeaxanthin on human macular pigment density and colour vision.
Rodriguez-Carmona M; Kvansakul J; Harlow JA; Köpcke W; Schalch W; Barbur JL
Ophthalmic Physiol Opt; 2006 Mar; 26(2):137-47. PubMed ID: 16460314
[TBL] [Abstract][Full Text] [Related]
26. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population.
Beatty S; Murray IJ; Henson DB; Carden D; Koh H; Boulton ME
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):439-46. PubMed ID: 11157880
[TBL] [Abstract][Full Text] [Related]
27. Effects of a lutein supplement on the plasma lutein concentration and macular pigment in patients with central serous chorioretinopathy.
Sawa M; Gomi F; Hara C; Nishida K
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5238-44. PubMed ID: 25074771
[TBL] [Abstract][Full Text] [Related]
28. Macular pigment and visual performance under glare conditions.
Stringham JM; Hammond BR
Optom Vis Sci; 2008 Feb; 85(2):82-8. PubMed ID: 18296924
[TBL] [Abstract][Full Text] [Related]
29. Monthly consistency of macular pigment optical density and serum concentrations of lutein and zeaxanthin.
Nolan JM; Stack J; Mellerio J; Godhinio M; O'Donovan O; Neelam K; Beatty S
Curr Eye Res; 2006 Feb; 31(2):199-213. PubMed ID: 16500771
[TBL] [Abstract][Full Text] [Related]
30. Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia.
Helb HM; Charbel Issa P; VAN DER Veen RL; Berendschot TT; Scholl HP; Holz FG
Retina; 2008 Jun; 28(6):808-16. PubMed ID: 18536596
[TBL] [Abstract][Full Text] [Related]
31. Preservation of visual sensitivity of older subjects: association with macular pigment density.
Hammond BR; Wooten BR; Snodderly DM
Invest Ophthalmol Vis Sci; 1998 Feb; 39(2):397-406. PubMed ID: 9478000
[TBL] [Abstract][Full Text] [Related]
32. [Objective measurement of macular optical density].
Dawczynski J; Schweitzer D; Lang GE
Klin Monbl Augenheilkd; 2011 Jan; 228(1):57-61. PubMed ID: 20714991
[TBL] [Abstract][Full Text] [Related]
33. Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study.
Koh HH; Murray IJ; Nolan D; Carden D; Feather J; Beatty S
Exp Eye Res; 2004 Jul; 79(1):21-7. PubMed ID: 15183097
[TBL] [Abstract][Full Text] [Related]
34. Lutein improves visual function in some patients with retinal degeneration: a pilot study via the Internet.
Dagnelie G; Zorge IS; McDonald TM
Optometry; 2000 Mar; 71(3):147-64. PubMed ID: 10970259
[TBL] [Abstract][Full Text] [Related]
35. Color matching in diabetes: optical density of the crystalline lens and macular pigments.
Davies NP; Morland AB
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):281-9. PubMed ID: 11773043
[TBL] [Abstract][Full Text] [Related]
36. The relationship of macular pigment optical density to serum lutein in retinitis pigmentosa.
Sandberg MA; Johnson EJ; Berson EL
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1086-91. PubMed ID: 19797209
[TBL] [Abstract][Full Text] [Related]
37. The relationship between foveal short-wavelength-sensitive visual function and macular pigment optical density in the ageing age.
Beirne RO
Vision Res; 2013 Jun; 86():81-6. PubMed ID: 23591086
[TBL] [Abstract][Full Text] [Related]
38. Nutritional manipulation of primate retinas. IV. Effects of n--3 fatty acids, lutein, and zeaxanthin on S-cones and rods in the foveal region.
Leung IY; Sandstrom MM; Zucker CL; Neuringer M; Max Snodderly D
Exp Eye Res; 2005 Nov; 81(5):513-29. PubMed ID: 15916761
[TBL] [Abstract][Full Text] [Related]
39. Idiopathic macular telangiectasia type 2: distribution of macular pigment and functional investigations.
Zeimer MB; Padge B; Heimes B; Pauleikhoff D
Retina; 2010 Apr; 30(4):586-95. PubMed ID: 20386096
[TBL] [Abstract][Full Text] [Related]
40. Impact of dietary carotenoid deprivation on macular pigment and serum concentrations of lutein and zeaxanthin.
Loughman J; Nolan JM; Beatty S
Br J Nutr; 2012 Dec; 108(11):2102-3. PubMed ID: 23098649
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
